Momina Krepost AD is engaged in the production and sales of medical products. The product portfolio includes syringes, injection needles, tubes, catheter, medical clothes, urine collecting bags, among others.
1966
69
Last FY Revenue $0.7M
Last FY EBITDA -$0.7M
$1.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Momina Krepost reported revenue of $0.7M and EBITDA of -$0.7M.
Momina Krepost expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Momina Krepost valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.7M | XXX | XXX | XXX |
Gross Profit | XXX | $0.3M | XXX | XXX | XXX |
Gross Margin | XXX | 36% | XXX | XXX | XXX |
EBITDA | XXX | -$0.7M | XXX | XXX | XXX |
EBITDA Margin | XXX | -96% | XXX | XXX | XXX |
EBIT | XXX | -$0.8M | XXX | XXX | XXX |
EBIT Margin | XXX | -112% | XXX | XXX | XXX |
Net Profit | XXX | -$1.0M | XXX | XXX | XXX |
Net Margin | XXX | -140% | XXX | XXX | XXX |
Net Debt | XXX | $0.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Momina Krepost has current market cap of BGN 2.0M (or $1.2M), and EV of BGN 2.5M (or $1.5M).
As of September 26, 2025, Momina Krepost's stock price is BGN 1 (or $1).
See Momina Krepost trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.5M | $1.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialMomina Krepost's trades at 2.0x EV/Revenue multiple, and -2.1x EV/EBITDA.
See valuation multiples for Momina Krepost and 15K+ public compsAs of September 26, 2025, Momina Krepost has market cap of $1.2M and EV of $1.5M.
Equity research analysts estimate Momina Krepost's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Momina Krepost's P/E ratio is not available.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $1.2M | XXX | $1.2M | XXX | XXX | XXX |
EV (current) | $1.5M | XXX | $1.5M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 2.0x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -2.1x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -1.8x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -1.2x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -3.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMomina Krepost's revenue per employee in the last FY averaged $11K, while opex per employee averaged $16K for the same period.
Momina Krepost's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Momina Krepost's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Momina Krepost and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -96% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $16K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 147% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Paragon Care | XXX | XXX | XXX | XXX | XXX | XXX |
SDI | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Momina Krepost acquired XXX companies to date.
Last acquisition by Momina Krepost was XXXXXXXX, XXXXX XXXXX XXXXXX . Momina Krepost acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Momina Krepost founded? | Momina Krepost was founded in 1966. |
Where is Momina Krepost headquartered? | Momina Krepost is headquartered in Bulgaria. |
How many employees does Momina Krepost have? | As of today, Momina Krepost has 69 employees. |
Is Momina Krepost publicy listed? | Yes, Momina Krepost is a public company listed on BUL. |
What is the stock symbol of Momina Krepost? | Momina Krepost trades under MKR ticker. |
When did Momina Krepost go public? | Momina Krepost went public in 1998. |
Who are competitors of Momina Krepost? | Similar companies to Momina Krepost include e.g. Ansell, Paragon Care, SDI, Polymed. |
What is the current market cap of Momina Krepost? | Momina Krepost's current market cap is $1.2M |
Is Momina Krepost profitable? | Yes, Momina Krepost is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.